Bicycle Therapeutics (BCYC) Free Cash Flow (2018 - 2026)

Bicycle Therapeutics has reported Free Cash Flow for 9 years, with the latest figure at -$66.6 million in Q1 2026.

• For the quarter ending Q1 2026, Free Cash Flow rose 23.38% year-over-year to -$66.6 million; the trailing twelve-month figure through Mar 2026 stood at -$231.7 million (down 27.27% YoY), and the FY2025 full-year result was -$252.0 million, down 51.86% from the prior year.
• Free Cash Flow for Q1 2026 stood at -$66.6 million, down from -$19.9 million in the prior quarter.
• The five-year high for Free Cash Flow was $33.8 million in Q2 2023, with the low at -$87.0 million in Q1 2025.
• Historically, Free Cash Flow has averaged -$38.4 million across 5 years, with a median of -$40.3 million in 2024.
• Annual changes were most pronounced in 2023 — Free Cash Flow soared 201.47% — and 2024, when it plunged 2537.0%.
• Bicycle Therapeutics' Free Cash Flow stood at -$31.8 million in 2022, then tumbled by 49.07% to -$47.3 million in 2023, then jumped by 79.37% to -$9.8 million in 2024, then sank by 104.01% to -$19.9 million in 2025, then tumbled by 234.53% to -$66.6 million in 2026.
• The last three Free Cash Flow figures came in at -$66.6 million (Q1 2026), -$19.9 million (Q4 2025), and -$71.8 million (Q3 2025), per Business Quant data.